January 1, 2023Rheumatology Advances in Practice7 citationsOpen Access

Discontinuation rate of sulfasalazine, leflunomide and methotrexate due to adverse events in a real-life setting (NOR-DMARD)

PMPaweł MielnikHelse Førde JSJoseph SextonUniversity of the Potomac KFK. M. FagerliDiakonhjemmet Hospital

Key Points

Key points are not available for this paper at this time.

Abstract

Our work has shown a similar AE profile of csDMARDs to previous data. However, higher discontinuation rates for SSZ and LEF cannot be explained easily from AE profiles.

Perguntar à IA

Bookmark

View Full Paper